# OXALIPLATIN
> **ANDA207325** · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2017-02-10
## Drug
- **FDA Application Number:** ANDA207325
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OXALIPLATIN
- **Generic name:** OXALIPLATIN
- **Active ingredients:** OXALIPLATIN
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** GLAND
- **Manufacturer:** Meitheal Pharmaceuticals Inc.
- **First approval:** 2017-02-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207325)
---
*AI Analytics · CC0 1.0*